17-80099790-T-C
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000574799.5(CCDC40):n.2981T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 1,610,396 control chromosomes in the GnomAD database, including 73,542 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000574799.5 non_coding_transcript_exon
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 15Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autoimmune diseaseInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000574799.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CCDC40 | NM_017950.4 | MANE Select | c.*15T>C | 3_prime_UTR | Exon 20 of 20 | NP_060420.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CCDC40 | ENST00000574799.5 | TSL:1 | n.2981T>C | non_coding_transcript_exon | Exon 16 of 16 | ||||
| CCDC40 | ENST00000397545.9 | TSL:5 MANE Select | c.*15T>C | 3_prime_UTR | Exon 20 of 20 | ENSP00000380679.4 |
Frequencies
GnomAD3 genomes AF: 0.352 AC: 53366AN: 151808Hom.: 10320 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.302 AC: 73977AN: 245030 AF XY: 0.305 show subpopulations
GnomAD4 exome AF: 0.288 AC: 420697AN: 1458470Hom.: 63205 Cov.: 35 AF XY: 0.290 AC XY: 210262AN XY: 725646 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.352 AC: 53424AN: 151926Hom.: 10337 Cov.: 32 AF XY: 0.350 AC XY: 26005AN XY: 74278 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:4
*15T>C in exon 20 of CCDC40: This variant is not expected to have clinical signi ficance because it has been identified in 49.7% (1929/3880) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs2304853).
Primary ciliary dyskinesia 15 Benign:3
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
not provided Benign:2
Primary ciliary dyskinesia Benign:1
Glycogen storage disease, type II Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at